Thermo Fisher Scientific Ion AmpliSeq

Ion AmpliSeq is a cutting-edge solution designed for targeted sequencing, enabling researchers to analyse specific genomic regions with exceptional accuracy and efficiency. This technology is pivotal in various applications, including gene expression profiling, mutation detection, and copy number variation analysis.

Key features of this system include:

• Customisable panels: Tailor-made to target specific genes or regions of interest, enhancing research flexibility.
• High sensitivity: Capable of detecting low-frequency variants, crucial for identifying rare mutations.
• Streamlined workflow: Simplifies the sequencing process, reducing time and labour.
• Low DNA input requirement: Ideal for samples with limited DNA availability, such as formalin-fixed, paraffin-embedded (FFPE) tissues.

This technology is widely applied in fields such as:

• Oncology: For identifying cancer-associated mutations and guiding personalised treatment strategies.
• Inherited disease research: To detect genetic variants linked to hereditary conditions.
• Infectious disease studies: For pathogen detection and characterisation.
• Pharmacogenomics: To understand genetic factors influencing drug response.

Commonly utilised in:

• Academic research institutions: For advancing genomic studies and discoveries.
• Clinical laboratories: To support diagnostic and prognostic assessments.
• Biotechnology companies: For developing and validating new therapeutic targets.
• Pharmaceutical firms: To facilitate drug development and personalised medicine approaches.

Introduced in the early 2010s, this system remains a cornerstone in genomic research, continually evolving to meet the dynamic needs of the scientific community.